在丙型肝炎病毒治疗效果更佳的时代，非酒精性脂肪性肝炎（NASH）患病率的上升会使NASH成为更致命的疾病吗？ - Suppr

Suppr

超能文献

Will the increased prevalence of nonalcoholic steatohepatitis (NASH) in the age of better hepatitis C virus therapy make NASH the deadlier disease?

作者信息

Rinella Mary E

出版信息

Hepatology. 2011 Oct;54(4):1118-20. doi: 10.1002/hep.24634.

DOI:10.1002/hep.24634

PMID:21956705

Abstract

摘要

相似文献

Will the increased prevalence of nonalcoholic steatohepatitis (NASH) in the age of better hepatitis C virus therapy make NASH the deadlier disease?在丙型肝炎病毒治疗效果更佳的时代，非酒精性脂肪性肝炎（NASH）患病率的上升会使NASH成为更致命的疾病吗？

Hepatology. 2011 Oct;54(4):1118-20. doi: 10.1002/hep.24634.

Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C.非酒精性脂肪性肝炎肝硬化与丙型肝炎肝硬化的长期预后比较。

Hepatology. 2003 Aug;38(2):420-7. doi: 10.1053/jhep.2003.50320.

Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH.伴有非酒精性脂肪性肝病/非酒精性脂肪性肝炎的丙型肝炎病毒相关肝硬化中的肝细胞癌的特殊组织学变异型：脂肪性肝炎相关肝细胞癌。

Am J Surg Pathol. 2010 Nov;34(11):1630-6. doi: 10.1097/PAS.0b013e3181f31caa.

Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.病态肥胖的肝脏组织病理学：其他形式慢性肝病的并发情况。

Obes Surg. 2006 Dec;16(12):1584-93. doi: 10.1381/096089206779319392.

Patients with NASH and cryptogenic cirrhosis are less likely than those with hepatitis C to receive liver transplants.非酒精性脂肪性肝炎（NASH）和隐源性肝硬化患者接受肝移植的可能性低于丙型肝炎患者。

Clin Gastroenterol Hepatol. 2011 Aug;9(8):700-704.e1. doi: 10.1016/j.cgh.2011.04.007. Epub 2011 Apr 15.

A comparison of the fibrotic potential of nonalcoholic fatty liver disease and chronic hepatitis C.非酒精性脂肪性肝病与慢性丙型肝炎纤维化潜能的比较。

Hum Pathol. 2010 Aug;41(8):1178-85. doi: 10.1016/j.humpath.2009.10.025. Epub 2010 Apr 22.

Fibrosis heterogeneity in nonalcoholic steatohepatitis and hepatitis C virus needle core biopsy specimens.非酒精性脂肪性肝炎和丙型肝炎病毒穿刺活检标本中的纤维化异质性

Am J Clin Pathol. 2005 Mar;123(3):382-7. doi: 10.1309/EY72-F1EN-9XCB-1KXX.

The relevance of liver histology to predicting clinically meaningful outcomes in nonalcoholic steatohepatitis.肝组织学对预测非酒精性脂肪性肝炎有临床意义结局的相关性。

Clin Liver Dis. 2012 Aug;16(3):487-504. doi: 10.1016/j.cld.2012.05.006. Epub 2012 Jun 27.

A prospective study of long-term outcomes in female patients with nonalcoholic steatohepatitis using age- and body mass index-matched cohorts.一项使用年龄和体重指数匹配队列对非酒精性脂肪性肝炎女性患者长期预后的前瞻性研究。

Acta Med Okayama. 2013;67(1):45-53. doi: 10.18926/AMO/49256.

Factors associated with the presence of nonalcoholic steatohepatitis in patients with chronic hepatitis C.慢性丙型肝炎患者中非酒精性脂肪性肝炎存在的相关因素。

Am J Gastroenterol. 2005 May;100(5):1091-8. doi: 10.1111/j.1572-0241.2005.41059.x.

引用本文的文献

Genomic, microbial and environmental standardization in animal experimentation limiting immunological discovery.动物实验中的基因组、微生物和环境标准化限制了免疫学发现。

BMC Immunol. 2020 Sep 2;21(1):50. doi: 10.1186/s12865-020-00380-x.

Sex-specific maternal calcium requirements for the prevention of nonalcoholic fatty liver disease by altering the intestinal microbiota and lipid metabolism in the high-fat-diet-fed offspring mice.通过改变高脂肪饮食喂养的后代小鼠的肠道微生物群和脂质代谢来预防非酒精性脂肪性肝病的母体钙的性别特异性需求。

Gut Microbes. 2020 Nov 1;11(6):1590-1607. doi: 10.1080/19490976.2020.1768645. Epub 2020 Jun 24.

Utility and variability of three non-invasive liver fibrosis imaging modalities to evaluate efficacy of GR-MD-02 in subjects with NASH and bridging fibrosis during a phase-2 randomized clinical trial.三种非侵入性肝纤维化成像方式的实用性和可变性，用于评估 GR-MD-02 在 NASH 合并桥接纤维化受试者中的疗效：一项 2 期随机临床试验。

PLoS One. 2018 Sep 7;13(9):e0203054. doi: 10.1371/journal.pone.0203054. eCollection 2018.

Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease.对非酒精性脂肪性肝病流行情况的建模显示，疾病负担呈指数级增长。

Hepatology. 2018 Jan;67(1):123-133. doi: 10.1002/hep.29466. Epub 2017 Dec 1.

Thermoneutral housing exacerbates nonalcoholic fatty liver disease in mice and allows for sex-independent disease modeling.热中性饲养会加剧小鼠的非酒精性脂肪性肝病，并使得能够建立不依赖性别的疾病模型。

Nat Med. 2017 Jul;23(7):829-838. doi: 10.1038/nm.4346. Epub 2017 Jun 12.

Regulation of Inflammation by IL-17A and IL-17F Modulates Non-Alcoholic Fatty Liver Disease Pathogenesis.IL-17A和IL-17F对炎症的调节作用影响非酒精性脂肪性肝病的发病机制。

PLoS One. 2016 Feb 19;11(2):e0149783. doi: 10.1371/journal.pone.0149783. eCollection 2016.

IL-17 Axis Driven Inflammation in Non-Alcoholic Fatty Liver Disease Progression.白细胞介素-17轴驱动非酒精性脂肪性肝病进展中的炎症反应。

Curr Drug Targets. 2015;16(12):1315-23. doi: 10.2174/1389450116666150531153627.

Therapy of experimental NASH and fibrosis with galectin inhibitors.半乳糖凝集素抑制剂治疗实验性非酒精性脂肪性肝炎和肝纤维化

PLoS One. 2013 Dec 18;8(12):e83481. doi: 10.1371/journal.pone.0083481. eCollection 2013.

Nutritional management of insulin resistance in nonalcoholic fatty liver disease (NAFLD).非酒精性脂肪性肝病（NAFLD）中胰岛素抵抗的营养管理。

Nutrients. 2013 Oct 11;5(10):4093-114. doi: 10.3390/nu5104093.

The relevance of liver histology to predicting clinically meaningful outcomes in nonalcoholic steatohepatitis.肝组织学对预测非酒精性脂肪性肝炎有临床意义结局的相关性。

Clin Liver Dis. 2012 Aug;16(3):487-504. doi: 10.1016/j.cld.2012.05.006. Epub 2012 Jun 27.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验